Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol. 2007 Jun 01; 25(16):2288-94.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.